A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease
- PMID: 16820420
- PMCID: PMC2077529
- DOI: 10.1136/jnnp.2005.086074
A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease
Abstract
Objective: To determine the usefulness of an interactive multimedia internet-based system (IMIS) for the cognitive stimulation of Alzheimer's disease.
Methods: This is a 24-week, single-blind, randomised pilot study conducted on 46 mildly impaired patients suspected of having Alzheimer's disease receiving stable treatment with cholinesterase inhibitors (ChEIs). The patients were divided into three groups: (1) those who received 3 weekly, 20-min sessions of IMIS in addition to 8 h/day of an integrated psychostimulation program (IPP); (2) those who received only IPP sessions; and (3) those who received only ChEI treatment. The primary outcome measure was the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog). Secondary outcome measures were: Mini-Mental State Examination (MMSE), Syndrom Kurztest, Boston Naming Test, Verbal Fluency, and the Rivermead Behavioral Memory Test story recall subtest.
Results: After 12 weeks, the patients treated with both IMIS and IPP had improved outcome scores on the ADAS-Cog and MMSE, which was maintained through 24 weeks of follow-up. The patients treated with IPP alone had better outcome than those treated with ChEIs alone, but the effects were attenuated after 24 weeks. All patients had improved scores in all of the IMIS individual tasks, attaining higher levels of difficulty in all cases.
Conclusion: Although both the IPP and IMIS improved cognition in patients with Alzheimer's disease, the IMIS program provided an improvement above and beyond that seen with IPP alone, which lasted for 24 weeks.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.J Alzheimers Dis. 2016;50(2):559-66. doi: 10.3233/JAD-150455. J Alzheimers Dis. 2016. PMID: 26757182 Free PMC article.
-
Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.Alzheimers Res Ther. 2017 Aug 31;9(1):70. doi: 10.1186/s13195-017-0294-2. Alzheimers Res Ther. 2017. PMID: 28859660 Free PMC article.
-
Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.Clin Ther. 2003 Jan;25(1):178-93. doi: 10.1016/s0149-2918(03)90023-3. Clin Ther. 2003. PMID: 12637119 Clinical Trial.
-
Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study.J Clin Psychiatry. 2002 Nov;63(11):972-80. doi: 10.4088/jcp.v63n1103. J Clin Psychiatry. 2002. PMID: 12444809
-
Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience.J Neural Transm (Vienna). 2016 Dec;123(12):1449-1455. doi: 10.1007/s00702-016-1606-6. Epub 2016 Sep 8. J Neural Transm (Vienna). 2016. PMID: 27631152
Cited by
-
Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain.J Alzheimers Dis. 2020;76(1):33-40. doi: 10.3233/JAD-200547. J Alzheimers Dis. 2020. PMID: 32538856 Free PMC article.
-
Computerized cognitive training for memory functions in mild cognitive impairment or dementia: a systematic review and meta-analysis.NPJ Digit Med. 2024 Jan 3;7(1):1. doi: 10.1038/s41746-023-00987-5. NPJ Digit Med. 2024. PMID: 38172429 Free PMC article. Review.
-
On the Effect of Previous Technological Experience on the Usability of a Virtual Rehabilitation Tool for the Physical Activation and Cognitive Stimulation of Elders.J Med Syst. 2015 Sep;39(9):104. doi: 10.1007/s10916-015-0297-0. Epub 2015 Aug 12. J Med Syst. 2015. PMID: 26265238 Clinical Trial.
-
Feasibility study of the BrightBrainer™ integrative cognitive rehabilitation system for elderly with dementia.Disabil Rehabil Assist Technol. 2015;10(5):421-32. doi: 10.3109/17483107.2014.900575. Epub 2014 Mar 29. Disabil Rehabil Assist Technol. 2015. PMID: 24679074 Free PMC article. Clinical Trial.
-
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.Cochrane Database Syst Rev. 2020 Feb 26;2(2):CD011961. doi: 10.1002/14651858.CD011961.pub2. Cochrane Database Syst Rev. 2020. PMID: 32101639 Free PMC article.
References
-
- Rogers S L, Friedhoff L T. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double‐blind, placebo‐controlled trial. The Donepezil Study Group. Dementia 19967293–303. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical